Shigematsu Works Co., Ltd. AI Stock Analysis
Want to see JP:7980 full AI Analyst Report?
Shigematsu Works Co., Ltd. (7980) AI Stock Analysis
Shigematsu Works Co., Ltd.
(TSE/TYO:7980)
The score is driven primarily by solid fundamentals but notably weak free cash flow, which tempers the otherwise improving balance sheet and revenue momentum. Technicals are currently bearish (below key moving averages with negative MACD), while the very low P/E and a modest dividend yield materially lift the overall rating.
Shigematsu Works Co., Ltd. (7980) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 5.74B
- Dividend Yield
- 1.85%
- Average Volume (3M)
- 28.82K
- Price to Earnings (P/E)
- 4.1
- Beta (1Y)
- 0.09
- Revenue Growth
- 12.91%
- EPS Growth
- 149.00%
- Country
- Japan
- Employees
- 399
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
Shigematsu Works Co., Ltd. Business Overview & Revenue Model
Company Description
Established in 1917 and headquartered in Tokyo, Japan, Shigematsu Works Co., Ltd. is a prominent Japanese manufacturer and distributor of safety and protective gear. The company's extensive product portfolio features various personal protective equip...
How the Company Makes Money
Shigematsu Works makes money primarily by manufacturing and selling respiratory protection products and the consumables that support their ongoing use. Its core revenue stream comes from sales of respirators (e.g., masks and breathing apparatus) to c...
Shigematsu Works Co., Ltd. Financial Statement Overview
Summary
Income statement and balance sheet are solid (re-accelerating revenue growth and improved leverage), but cash flow is a major drag: free cash flow is negative in both 2025 and 2026 and does not cover earnings, signaling weak cash conversion despite profitability.
Income Statement
71PositiveBalance Sheet
74PositiveCash Flow
41Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.95B | 15.59B | 14.11B | 13.00B | 12.88B | 11.92B |
| Gross Profit | 4.79B | 4.61B | 4.30B | 3.93B | 4.01B | 3.63B |
| EBITDA | 2.11B | 1.97B | 1.73B | 1.31B | 1.69B | 1.25B |
| Net Income | 787.88M | 702.20M | 780.58M | 584.08M | 748.24M | 589.11M |
Balance Sheet | ||||||
| Total Assets | 21.49B | 21.59B | 18.17B | 16.22B | 15.32B | 14.32B |
| Cash, Cash Equivalents and Short-Term Investments | 1.76B | 2.45B | 1.48B | 1.63B | 1.63B | 1.35B |
| Total Debt | 7.05B | 7.63B | 5.04B | 3.12B | 3.13B | 3.36B |
| Total Liabilities | 11.73B | 12.15B | 9.61B | 7.94B | 7.97B | 7.83B |
| Stockholders Equity | 9.76B | 9.44B | 8.57B | 8.28B | 7.35B | 6.50B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -1.49B | -1.65B | 399.81M | 667.73M | 26.94M |
| Operating Cash Flow | 0 | 1.21B | 228.18M | 966.39M | 1.12B | 490.66M |
| Investing Cash Flow | 0 | -2.73B | -2.21B | -838.81M | -643.92M | -496.46M |
| Financing Cash Flow | 0 | 2.49B | 1.83B | -125.72M | -299.93M | -173.66M |
Shigematsu Works Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7980, the sentiment is Negative. The current price of 809.00 is below the 20-day moving average (MA) of 840.60, below the 50-day MA of 851.74, and below the 200-day MA of 863.12, indicating a bearish trend. The MACD of -15.48 indicates Positive momentum. The RSI at 41.89 is Neutral, neither overbought nor oversold. The STOCH value of 38.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7980.
Shigematsu Works Co., Ltd. Peers Comparison
Overall Rating
JP:773079Outperform
JP:774772Outperform
JP:798064Neutral
JP:771660Neutral
JP:770256Neutral
JP:808648Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | JPY 146.30B | 20.33 | ― | 2.75% | 10.18% | 55.86% | |
| 72Outperform | JPY 1.02T | 31.57 | 19.88% | 1.25% | 21.16% | 156.97% | |
| 64Neutral | JPY 5.78B | 4.07 | ― | 1.85% | 12.91% | 149.00% | |
| 60Neutral | JPY 248.88B | 101.92 | 1.89% | 2.06% | 14.87% | -55.19% | |
| 56Neutral | JPY 10.55B | -14.93 | ― | 3.96% | -3.10% | -645.01% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 48Neutral | JPY 246.65B | 20.41 | 3.85% | 2.33% | 5.03% | -0.86% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7980 | Shigematsu Works Co., Ltd. | 809.00 | 39.12 | 5.08% | |
| JP:7747 | Asahi Intecc Co | 3807.00 | 1457.82 | 62.06% | |
| JP:7716 | Nakanishi | 1409.00 | 405.86 | 40.46% | |
| JP:8086 | Nipro Corporation | 1331.00 | -121.91 | -8.39% | |
| JP:7702 | JMS Co., Ltd. | 429.00 | 4.40 | 1.04% | |
| JP:7730 | Mani, Inc. | 1489.00 | 64.46 | 4.52% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 12, 2026
